Skip to main content

ScienceDex / Researcher record

Nemazee, David

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #4,601
  • Sustained Excellence
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

$1.8M
Full award amounts, FY2023
3
Records listing this PI
#4,601
By linked amount among FY2023 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$1,726,2755#2,538
2007$2,121,9566#2,449
2008$1,710,7775#3,055
2009$2,536,4687#2,313
2010$2,460,6937#2,596
2011$1,398,2884#4,647
2012$959,3423#7,374
2013$1,203,1044#5,074
2014$761,1102#9,448
2015$1,020,3532#6,706
2016$1,309,1033#4,916
2017$3,657,1955#940
2018$3,392,9304#1,149
2019$4,054,0465#933
2020$5,118,0718#171
2021$5,039,0637#686
2022$2,890,2734#1,857
2023$1,768,4023#4,601

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20065 records
  2. FY20076 records
  3. FY20085 records
  4. FY20097 records
  5. FY20107 records
  6. FY20114 records
  7. FY20123 records
  8. FY20134 records
  9. FY20142 records
  10. FY20152 records
  11. FY20163 records
  12. FY20175 records
  13. FY20184 records
  14. FY20195 records
  15. FY20208 records
  16. FY20217 records
  17. FY20224 records
  18. FY2023 · selected3 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Nemazee, David. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award records by amount

NIH award records listing Nemazee, David as a PI. Multi-PI records show the full award amount for context.

  • 5R01AI137252-04R01Contact PI
    Functional Analysis of MicroRNAs and Target Genes in Immune Tolerance
    $649.4K
    award amount
  • 5R01AI073148-15R01Contact PI
    Knock-in mice expressing germline-reverted broadly neutralizing HIV antibodies
    $635.3K
    award amount
  • 5R01AI142945-05R01Contact PI
    Functions of novel phospholipase D proteins in nucleic acid sensing
    $483.8K
    award amount

Award organization

Organizations that administered FY2023 awards listing Nemazee, David as a PI.

FY2023 award administered by Scripps Research Institute (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Scripps Research Institute
  2. 2006
    $500K Cumulative Funding
  3. 2006
    $1M Cumulative Funding
  4. 2006
    Entered Top 50% Nationally
    Ranked #2538
  5. 2006
    Entered Top 25% Nationally
    Ranked #2538
  6. 2007
    $2M Cumulative Funding
  7. 2008
    $5M Cumulative Funding
  8. 2010
    $10M Cumulative Funding
  9. 2012
    R01 Grant Holder
  10. 2017
    Entered Top 10% Nationally
    Ranked #940
  11. 2017
    Entered Top 5% Nationally
    Ranked #940
  12. 2019
    $25M Cumulative Funding
  13. 2020
    Entered Top 1% Nationally
    Ranked #171